Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PBMWW
PSYENCE BIOMEDICAL LTD. WARRANT
NASDAQ
$0.03
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$2.14 K
52w High$0.03
52w Low$0.02
Dividend Yield—
Frequency—
P/E—
Volume11.95K
Shares Out.71.27K

COMPANY

LEADERSHIP

Jody Aufrichtig
CHIEF EXECUTIVE
Jody Aufrichtig

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 26, 2024
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
12

PRICE

$0.03 ▲ UP 0.00% (+$0.00)
$0.03$0.03$0.03$0.039:46 AM10:46 AM11:45 AM12:44 PM1:44 PM2:43 PM3:43 PM0.03

About Psyence Biomedical Ltd. Warrant

https://www.psyencebiomed.com ↗

Psyence Biomedical Ltd., based in Toronto, develops botanical psilocybin-based medicines, with its lead product PEX010 in Phase IIb for treating anxiety, depression, and adjustment disorder in palliative care patients.

INDUSTRY

Biotechnology

A PRODUCT PSYENCE BIOMEDICAL LTD. WARRANT IS KNOWN FOR

PEX010
PEX010

PEX010, Psyence Biomedical's lead psilocybin capsule, is in Phase IIb trials for treating Adjustment Disorder in terminal cancer patients, reflecting the company's focus on nature-derived psychedelics for mental health therapy.

COMPETITORS

COMPETITOR
ATAI COMPARE
CMPS COMPARE
GHRS COMPARE